BioCentury
ARTICLE | Clinical News

CarboMed preclinical data

November 2, 1998 8:00 AM UTC

Vanderbilt University researchers reported in the Proceedings of the National Academy of Sciences that CM101, an angiogenesis inhibitor under investigation to treat cancer, allowed mice paralyzed by a...